Your session is about to expire
← Back to Search
Radiation
Hypofractionated Whole Breast Radiation Therapy for Breast Carcinoma
N/A
Waitlist Available
Led By Afshin Forouzannia, M.D.
Research Sponsored by St. Joseph Hospital of Orange
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights
Study Summary
This trial is testing whether a combined schedule of radiation therapy is superior to the standard schedule in terms of local control and cosmetic outcome.
Eligible Conditions
- Breast Carcinoma
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Assessment of acute and late toxicity
Secondary outcome measures
Cosmetic Evaluation
Disease Free Survival
Overall Survival
Trial Design
1Treatment groups
Experimental Treatment
Group I: Intraoperative Electron Radiation TherapyExperimental Treatment2 Interventions
A single dose of electron irradiation given at the surgical site during the operation to remove the cancerous tumor will replace the usual 5-8 days of localized radiation. Hypofractionated Whole Breast Radiation Therapy must start within 14-56 days post operatively.
Find a Location
Who is running the clinical trial?
St. Joseph Hospital of OrangeLead Sponsor
9 Previous Clinical Trials
864,883 Total Patients Enrolled
Afshin Forouzannia, M.D.Principal InvestigatorThe Center for Cancer Prevention & Treatment at St. Joseph Hospital of Orange
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger